Blueprint Medicines (BPMC)
(Delayed Data from NSDQ)
$116.32 USD
+4.62 (4.14%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $116.30 -0.02 (-0.02%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -1.30 |
EPS Last Quarter | -1.32 |
Last EPS Surprise | 19.51% |
ABR | 1.76 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.45 |
Next Year | -2.25 |
EPS (TTM) | -7.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 102.68M | 112.99M | 433.85M | 655.19M |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 112.00M | 132.20M | 494.10M | 964.00M |
Low Estimate | 98.08M | 103.33M | 409.53M | 585.19M |
Year ago Sales | 57.57M | 56.57M | 249.38M | 433.85M |
Year over Year Growth Est. | 78.36% | 99.73% | 73.97% | 51.02% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.30 | -1.14 | -2.45 | -2.25 |
# of Estimates | 10 | 9 | 8 | 11 |
Most Recent Consensus | -1.10 | -0.87 | -1.10 | -3.09 |
High Estimate | -1.10 | -0.87 | -1.10 | 1.71 |
Low Estimate | -1.43 | -1.36 | -5.38 | -3.98 |
Year ago EPS | -2.19 | -2.20 | -8.37 | -2.45 |
Year over Year Growth Est. | 40.64% | 48.18% | 70.73% | 8.28% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.30 | -1.14 | -2.45 | -2.25 |
7 Days Ago | -1.30 | -1.14 | -2.45 | -2.25 |
30 Days Ago | -1.30 | -1.14 | -2.45 | -2.25 |
60 Days Ago | -1.31 | -1.15 | -2.94 | -2.07 |
90 Days Ago | -1.43 | -1.26 | -5.49 | -2.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.30 | -1.14 | -2.45 | -3.09 |
Zacks Consensus Estimate | -1.30 | -1.14 | -2.45 | -2.25 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -37.28% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.32 | -1.82 | -2.20 | -2.19 | NA |
Estimate | -1.64 | -2.04 | -2.39 | -2.58 | NA |
Difference | 0.32 | 0.22 | 0.19 | 0.39 | 0.28 |
Surprise | 19.51% | 10.78% | 7.95% | 15.12% | 13.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more